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reaction was quenched after 1 h by addition of 0.05 M HCl (50 mL). The mixture was extracted 3 times with DCM (75 mL). The combined organic was dried over MgSO 4 and concentrated. The resulting yellow oil was purified by silica column (3% MeOH in DCM) to yield compound 4 as a yellow solid (0.837 g, 48.5 %). 13 C NMR (151 MHz, DMSO) δ 171. 8, 164.9, 164.4, 153.4 147.86, 139.34, 131.82, 130.9, 126.4, 124.7, 110.7, 108.2, 99.5, 63.0, 56.3, 56.1, 52.3, 38.1, 30.3, 28.6, 22.8 . Polymer 1. Compound 4 (150 mg, 0.33 mmol) and Compound 5 ( 90 mg, 0.33 mmol) were dissolved in DMSO (0.9 mL). Triethylamine ( 0.28 mL, 2.00 mmol) then 1, 3-propanedithiol ( 72 mg, 0.67 mmol) were added to the solution dropwise. The reaction was stirred at room temperature for 140 h. The reaction mixture was quenched by precipitating with cold ether (40 mL). The polymer was further purified by dissolving in DCM and precipitating into cold ether three (40 mL) times to yield yellow polymer (131 mg, 42 %). M w of 13900 Da, PDI of 1.71 (characterized by GPC relative to poly(methyl methacrylate) standards 
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Degradation of polymer 1
Degradation of polymer 1 followed 1 H NMR. A concentrated solution of polymer 1 (12.5 mg/ mL) was prepared in d 6 -DMSO. The DMSO stock was divided and an appropriate amount of deuterated sodium phosphate buffer at pH 7.4 (0.1 M) and sodium phosphate solution at pH 5 were added to make 9:1 solutions of d 6 -DMSO:PBS. The solution was irradiated for 1 to 20 min in a 1.7 mm Bruker NMR tube in a Luzchem photoreactor. The samples were then incubated at 37 o C for the specified times. Spectra were taken on a 600 MHz Bruker spectrometer after the prescribed incubation times. buffer (6 mL), and probe sonicated for 4 min at 9-10W (Qsonica Sonicator 4000). DCM was then removed by stirring at 600 RPM under house vacuum for 3 h. Remaining PVA was removed by tangential flow filtration (Millipore Pellicon XL, 500 kDa) using 10 mM Tris pH 8.0 buffer (250 mL) at 45 RPM. The retentiate was freeze-dried with 100 mg trehalose as cryoprotectant. The size and distribution of particles were determined by dynamic light scattering (DLS, Malvern Instruments S10 Nanosizer) and transmission electron microscopy (TEM, Tecnai FEI Spirit). Loading and encapsulation efficiency was assessed by dissolving lyophilized powder in DCM, extracting FDA into NaOH (0.1 N) and measuring fluorescence of the aqueous phase against a calibration curve in 0.1 N NaOH (Horiba Jobin Yvon FL-1000). Later changes are the result of slower subsequent hydrolysis and aggregation.The PDI of non-irradiated particles also slowly increases over time due to slow hydrolysis and subsequent aggregation.
Nile Red quenching. Freeze-dried Nile Red-containing particles were re-suspended in 1x PBS pH 7.4
buffer (1 mg/mL). Quenching of Nile Red fluorescence upon degradation and solubility change was followed by the decrease in the 620 nm fluorescence peak (Horiba Jobin Yvon FL-1000). Suspensions were irradiated for 1, 3, or 5s intervals (1.5 mW/cm 2 , 300-400 nm, λ max = 365 nm), incubating 10 min in between each consecutive irradiation.
In vitro release from particles
Release in 264.7 Raw cells. Raw 264.7 mouse macrophage cells were seeded at 20000 cells/well in DMEM (Corning) supplemented with 10% Fetal Bovine Serum (FBS, HyClone) and 1% penicillinstreptomycin (Invitrogen) on a 96-well tissue culture-treated plate (Corning) overnight prior to the experiment. Lyophilized FDA-containing particles (10 mg) were resuspended in clear DMEM/FBS (1 mL, no phenol red, Corning). The cells were double washed with warm PBS (100 µL twice) and the particle suspensions in media were added (100 µL). Free FDA ( 0.1 mg/mL) and empty particles were S12 used as controls. After 3h incubation at 37 °C, in 5% CO 2 atmosphere, the cells were again double washed with warm PBS (100 µL twice) and clear media (100 µL) was added to each well. Half of the plate was then irradiated for 5 min (10 mW/cm 2 , λex = 320-480 nm) using the Omnicure. Following a 30 min incubation at 37 °C, in 5% CO 2 , the release of FDA was measured by fluorescence measurement (λex = 495 nm, λem = 514 nm) using a plate reader (Molecular Devices SpectraMax M5). To confirm release, fluorescence microscopy images of cells were acquired (Nikon TS100F).
Cytotoxicity assays
Polymer Cytotoxicity. Polymer 1 (5 mg) was dissolved in sterile DMSO (10 µL), and the solution was subsequently added to clear DMEM (990 µL). The resulting suspension was sonicated until uniform and then further diluted to appropriate concentrations in DMEM/FBS media. Lyophilized particles containing FDA (5 mg) were resuspended in sterile media (1 mL) and half of the volume was irradiated for 5 min with UV light (10 mW/cm 2 , λex = 320-480 nm, OmniCure S2000 Curing System). The solutions were then diluted to appropriate concentrations in cell culture media. 24 hours prior to incubation, Raw 264.7 cells were seeded on a tissue culture treated 96-well plate (Corning) at a density of 20000 cells/well in DMEM media. The cells were washed twice with 100 µL PBS at 37 °C, and then incubated with the polymer/particle suspensions in triplicates for 24 h at 37 °C, in 5% CO 2 . Following incubation with particles, cells were again washed twice with 100 µL PBS. Following the MTT assay kit instructions, the cells were then incubated at 37°C, in 5% CO 2 for 3 h in 100 µL DMEM containing 0.5 mg/mL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT agent, Sigma-Aldrich, USA). Triton-X (1% w/v, Sigma-Aldrich) was used as a positive apoptosis control. After the incubation, 100 µL of MTT solution (Sigma-Aldrich) was added to each well and the solution was thoroughly triturated to fully solubilize formazan crystals. To quantify mitochondrial activity, absorbance at 570 nm normalized to background absorbance at 690 nm was measured using a plate reader (Molecular Devices SpectraMax M5).
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Figure S7: MTT assay of polymer 1.
Particle Cytotoxicity.
Lyophilized empty polymer 1 nanoparticles were re-suspended in sterile DMEM/FBS media (1 mL) and diluted to appropriate concentrations in cell culture media. 24 hours prior to incubation, Raw 264.7 cells were seeded on a tissue culture treated 96-well plate (Corning) at a density of 20000 cells/well in DMEM media. The cells were washed twice with 100 µL PBS at 37 °C, and then incubated with the particle suspensions in triplicates for 3 h at 37 °C, in 5% CO 2 . Following incubation with particles, half of the plate was irradiated for 5 min with UV light (10 mW/cm 2 , λex = 320-480 nm, OmniCure S2000 Curing System). Cells were then incubated for an additional 24h at 37 °C, in 5% CO 2 . Subsequently, cells were washed twice with 100 µL PBS. Following the MTT assay kit instructions, the cells were then incubated at 37°C, in 5% CO 2 for 3 h in 100 µL DMEM containing 0.5 mg/mL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT agent, Sigma-Aldrich, USA). Triton-X (1% w/v, Sigma-Aldrich) S14 was used as a positive apoptosis control. After the incubation, 100 µL of MTT solution (Sigma-Aldrich) was added to each well and the solution was thoroughly triturated to fully solubilize formazan crystals. To quantify mitochondrial activity, absorbance at 570 nm normalized to background absorbance at 690 nm was measured using a plate reader (Molecular Devices SpectraMax M5). Compound 7. Compound 2 . dicyclohexylamine (2.00 g, 3.79 mmol) and cesium carbonate (2.07 g, 6.35 mmol) were suspended in DMF (30 mL). Benzyl bromide (0.75 mL, 6.35 mmol) was added to the solution dropwise and the mixture was allowed to react for 18 h. The reaction mixture was diluted with DI H 2 O (80 mL) and extracted 3 times with DCM (50 mL). The organic layer was dried over MgSO 4 and concentrated. The resulting colorless oil was purified by silica column ( 1:3 Ethyl Acetate/ Hexane) to yield compound 7 as a colorless oil (1.65 g, 99 %). 6, 156.0, 155.4, 135.4, 128.7, 128.6, 128.5, 80.0, 79.3, 67.1, 53.5, 40.2, 32.5, 29.7, 28.6, 28 .5.
Compound 8. Compound 7 (1.65 g, 3.78 mmol) was dissolved in DCM (18 mL) and TFA (18 mL) and stirred for 1.2 h. The reaction mixture was concentrated. The resulting colorless oil was dissolved in DCM (40 mL) and concentrated 3 more times. The oil was then dissolved in DCM (37 mL) and Et 3 N (4.32 mL, 30.98 mmol) was dripped into the solution slowly and the solution was chilled to 0 o C.
Acryloyl chloride ( 0.69 mL, 8.52 mmol) was dripped into the reaction mixture over a period of 10 min. 4, 166.1, 165.7, 135.4, 131.0, 130.5, 128.8, 128.6, 128.4, 127.3, 126.4, 67.4, 52.0, 38.8, 32.0, 28.7, 22. 
Degradation of control polymer 9
Deprotection of polymer 9 via hydrogenation. Polymer 9 (15 mg) was dissolved in THF (4 mL) under argon. Pd/C 10% (10 mg) was added and the reaction was put under an H 2 atmosphere. The reaction was allowed to proceed for 15 h then was flushed with argon, filtered through celite, then concentrated. The resulting oil was used directly in 1 H NMR experiments. The hydrogenation appeared to remove roughly 50% of the protecting group ( Figure S8 ). This is likely due to poisoning of the palladium catalyst with residual thiols.
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Figure S10: Hydrogenated polymer 9.
Degradation of polymer 9 followed 1 H NMR. A concentrated solution of polymer 9 (12.5 mg/ mL) was prepared in d 6 -DMSO. An appropriate amount of deuterated sodium phosphate buffer at pH 7.4 (0.1 M) was added to make 9:1 solutions of d 6 -DMSO:PBS and was separated to two samples. One sample was irradiated for 20 min in a 1.7 mm Bruker NMR tube in a Luzchem photoreactor. One sample of polymer 9
was not irradiated. Hydrogenated polymer 9 was prepared in d 6 -DMSO (22 mg/ mL) and an appropriate amount of deuterated sodium phosphate buffer at pH 7.4 (0.1 M) was added to make a 9:1 solutions of d 6 -DMSO:PBS solution. The samples were then incubated at 37 o C for the specified times. Spectra were taken on a 600 MHz Bruker spectrometer after the prescribed incubation times.
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Figure S11 
